Trials / Completed
CompletedNCT00068081
Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
A Randomized, Double-Blind, Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (planned)
- Sponsor
- NeurogesX · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the efficacy, safety and tolerability of NGX 4010 applied for 60 minutes for the treatment of PHN.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Capsaicin Dermal Patch |
Timeline
- First posted
- 2003-09-09
- Last updated
- 2008-03-06
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00068081. Inclusion in this directory is not an endorsement.